Advent in German pharma LBO
The UK-based private equity firm continues to invest in pharmaceuticals with the E375m acquisition of German-based Viatris.
The UK-based private equity firm continues to invest in pharmaceuticals with the E375m acquisition of German-based Viatris.
Copyright PEI Media
Not for publication, email or dissemination